AzTrials
AzTrials

Asthma in ChildrenAIRNCT07738016

Artificially Intelligent Robot Control

A study testing Standard Asthma Education in people with Asthma in Children and Artificial Intelligence, run by University of Miami at 1 site in United States.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The purpose of the study is to compare the impact of standard asthma education with the standard + Artificially Intelligent Robot (AIR) Control intervention. Read more about this study

Who is it for?
Ages 4 years and older
What is being tested?
Standard Asthma Education
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteUnited States
Study dates
Oct 2026to 30 Aug 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 4 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • The participant must be at least 18 years old.
  • The participant must be willing and able to participate.
  • The participant can read English or Spanish and is able to fill out survey instruments by themselves or with assistance.
  • The participant cares for a child age 4-11 with asthma.
  • The participant must be at least 4 years old - 11 years old with asthma.
  • The child can speak English or Spanish.
  • The participant must assent to participation.
  • The participant's guardian must have consented.

Who cannot join

  • The participant is younger than 18 years old.
  • The participant is unwilling to participate in the study.
  • The participant is unable to complete survey instruments.
  • The participant does not care for a child with asthma who is age 4-11.
  • The participant is younger than 4 years old, over 11 years old, or does not have asthma.
  • The child does not speak English or Spanish.
  • The participant is unwilling to participate in the study.
  • The participant's guardian did not consent.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Cynthia L Foronda, PhD contact

305-284-1525

c.foronda@miami.edu

Ubbo Visser, PhD contact

305-284-2254

ubbo.visser@gmail.com

United States1 site
  • Holtz Children's Hospital

    Miami, Florida, 33136

    Bridgette Johnson, PhD, 954-562-6480, Bridgette.Johnson@jhsmiami.org

Other trials in United States

About this study

Official title: Asthma Under Artificially Intelligent Robot (AIR) Control: Robotic Support for Pediatric Education

The purpose of the study is to compare the impact of standard asthma education with the standard + Artificially Intelligent Robot (AIR) Control intervention.

Being tested
Artificially Intelligent Robot (AIR) Control Intervention, Standard Asthma Education
Medical subject headings
Caregiver Burden

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Artificially Intelligent Robot (AIR) Control InterventionBehavioural

    Participants will receive a single 10-minute robotic asthma education session delivered by the Artificially Intelligent Robot (AIR) during their hospital admission.

  • Standard Asthma EducationBehavioural

    Participants will receive the standard asthma education provided by their healthcare provider during their hospital admission.

Study groups in NCT07738016
Study groupRoleWhat they receive
Standard Asthma Education Plus Artificially Intelligent Robot (AIR) Control InterventionExperimentalParticipants in this arm will receive the standard asthma education plus one Artificially Intelligent Robot (AIR) supported education session lasting approximately 10 minutes during their hospital admission.
Receives: Behavioral: Artificially Intelligent Robot (AIR) Control Intervention; Behavioral: Standard Asthma Education
Standard Asthma Education (Control)Active comparatorParticipants in this arm will receive one standard asthma education session during their hospital admission lasting approximately 10 minutes.
Receives: Behavioral: Standard Asthma Education

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Child Inhaler Technique Score

    Measured using the Children's Hospital Colorado Inhaler Technique Coaching Tool. The tool uses a 0-10 point scale, where 0 indicates no correct steps and 10 indicates all steps performed correctly. Higher scores indicate better technique.

    Measured: Within 1 hour following completion of the education session

  2. Medication Adherence (Neuro-Quality of Life Medication Adherence Short Form 6a Score)

    Medication adherence will be assessed using the Neuro-Quality of Life Medication Adherence Short Form 6a, a 6-item patient-reported outcome measure. Scores range from 6-30. Scores are reported as standardized T scores. Higher T scores indicate better medication adherence.

    Measured: Baseline, 2-4 months, and 5-7 months post-intervention

  3. Asthma Control (Childhood Asthma Control Test)

    Asthma control will be assessed using the Childhood Asthma Control Test (C-ACT) for children 4 to 11 years), a 7-item patient-reported measure. The C-ACT produces a total score ranging from 0 to 27. Item responses are summed with higher scores indicating better asthma control.

    Measured: Baseline, 2-4 months, and 5-7 months post-intervention

  4. Caregiver Illness Burden (Patient-Reported Outcomes Measurement Information System Illness Burden - Short Form 6a)

    Caregiver illness burden will be assessed using the Patient-Reported Outcomes Measurement Information System (PROMIS) Illness Burden - Short Form 6a, a 6-item patient-reported measure. Scoring ranges from 6-30. Item responses are summed and converted to a standardized T-score (mean = 50, standard deviation = 10) with higher T-scores indicating greater illness burden.

    Measured: Baseline, 2-4 months, and 5-7 months post-intervention

  5. Healthcare Utilization

    Healthcare utilization will be assessed using the Healthcare Utilization Survey, a 4-item caregiver-reported measure, ranging from 4-20. Healthcare utilization is assessed as the number of times the child has visited a healthcare facility (total number of visits indicated by the caregiver), with higher values indicating higher healthcare utilization.

    Measured: Baseline, 2-4 months, and 5-7 months post-intervention

Secondary outcomes (1)
  1. Pulmonary function (Forced Expiratory Volume in 1 second/ Forced Vital Capacity )

    Pulmonary function will be assessed using Forced Expiratory Volume in 1 second/ Forced Vital Capacity (FEV1/FVC) extracted from the electronic health record. This ratio compares the volume of air exhaled in the first second (FEV1) to the total amount of air exhaled (FVC). FVC is interpreted by using a z score or Lower Limit of Normal (LLN) from the Global Lung Function Initiative (GLI) 2012 reference equations. A score of ≥80% predicted or z-score of-1.64 or higher is considered normal pulmonary function with higher scores indicating higher pulmonary function. A score of <80% predicted or z-score of -1.64 or lower is considered poor pulmonary function.

    Measured: Baseline, 2-4 months post-intervention, and 5-7 months post-intervention.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Jul 2026
  2. Study startOct 2026 (estimated)
  3. Primary completion30 Aug 2027 (estimated)
  4. Study completion30 Aug 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07738016
Sponsor's protocol ID
20260782
Acronym
AIR
Status last verified
Sep 2026
First submitted
27 Jul 2026
Last updated
16 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data (IPD) will not be shared publicly. De-identified, aggregate-level data may be made available upon reasonable request to the Principal Investigator after study completion, contingent on approval by the Institutional Review Board (IRB), execution of a data use agreement, and confirmation that the proposed use is consistent with the informed consent and applicable privacy regulations. No direct identifiers will be shared. Data will be retained and managed in accordance with institutional policies and federal regulations.

Publications

  • Foronda C, Gonzalez JM, Snowden K, Prather S, Majilton C, Weisman A, Parmeter S, Herrera A, Gattamorta KA, Gonzalez JE, Downs C, Hooshmand M, Cardenas M. Improving knowledge and decreasing depressive symptoms in caregivers of children with asthma through the asthma academy: A randomized controlled trial. Int J Nurs Stud Adv. 2021 Oct 9;3:100047. doi: 10.1016/j.ijnsa.2021.100047. eCollection 2021 Nov.

    PubMed 38746721
  • Foronda CL, Kelley CN, Nadeau C, Prather SL, Lewis-Pierre L, Sarik DA, Muheriwa SR. Psychological and Socioeconomic Burdens Faced by Family Caregivers of Children With Asthma: An Integrative Review. J Pediatr Health Care. 2020 Jul-Aug;34(4):366-376. doi: 10.1016/j.pedhc.2020.02.003. Epub 2020 Apr 14.

    PubMed 32299726
  • Prather SL, Foronda CL, Kelley CN, Nadeau C, Prather K. Barriers and Facilitators of Asthma Management as Experienced by African American Caregivers of Children with Asthma: An Integrative Review. J Pediatr Nurs. 2020 Nov-Dec;55:40-74. doi: 10.1016/j.pedn.2020.06.012. Epub 2020 Jul 10.

    PubMed 32653828
  • Foronda C, Prather S, Snowden K, Gonzalez JM, Gattamorta KA, Lee J, Gonzalez JE, Cardenas M. Asthma academy: A student nurse-led telehealth education program for low-income family caregivers of children with asthma. Nurs Open. 2022 Mar;9(2):1486-1496. doi: 10.1002/nop2.1123. Epub 2021 Dec 16.

    PubMed 34913268

Questions about this trial

What is this clinical trial studying?

A study testing Standard Asthma Education in people with Asthma in Children and Artificial Intelligence, run by University of Miami at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 16 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Cynthia L Foronda, PhD (305-284-1525, c.foronda@miami.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Child Inhaler Technique Score (time frame: Within 1 hour following completion of the education session). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07738016, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Sep 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in